BMRN · Stage, GEX levels and seasonality
BioMarin Pharmaceuticals Inc (BMRN)
Last close $54.89 (-0.56%) on 2026-10-08
No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.
Open the chartWeinstein stage
Stage 3B — Topping · 1 weeks in this stage · 30-week average $58.39
Stage 3 (topping): the advance stalls and the 30-week average flattens.
What would change it: Stage 4 begins on a weekly close below 53.9 (the top's support) under a flat or falling 30-week SMA.
GEX levels
| Put wall | Gamma flip | Call wall |
|---|---|---|
| 60 | 60.82 | 62.5 |
Set before the open on 2026-10-02. Members see today's levels, updated every 15 minutes. How to read GEX.
Seasonality
| Month | Average return | Months up | Years |
|---|---|---|---|
| January | -2.57% | 25% | 4 |
| February | +2.65% | 50% | 4 |
| March | -7.27% | 25% | 4 |
| April | -1.63% | 25% | 4 |
| May | -3.03% | 25% | 4 |
| June | +1.13% | 50% | 4 |
| July | +1.82% | 100% | 4 |
| August | +6.12% | 100% | 4 |
| September | -11.9% | 0% | 4 |
| October (this month) | -5.86% | 0% | 3 |
| November | +6.56% | 67% | 3 |
| December | +3.94% | 100% | 3 |
Based on up to 4 years of weekly closes. Past seasonality does not predict future returns.
On Signa plans
The Signa score and Action Card for BMRN, live options flow, dark pool prints, today's GEX levels with vanna and charm, and what 40+ AI agents say about it.
No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.
Questions about BMRN
What Weinstein stage is BMRN in?
BMRN is in Stage 3B — Topping, for 1 weeks, based on completed weekly bars and its 30-week moving average (58.39).
How has BMRN done in October?
Over the last 3 years, BMRN averaged -5.86% in October and rose in 0% of them. Past seasonality does not predict future returns.
What are BMRN's GEX levels?
Before the open on 2026-10-02, BMRN's put wall was 60, gamma flip 60.82 and call wall 62.5. Signa members see today's levels, updated every 15 minutes.
Educational content only, not financial advice. Trading involves substantial risk.